|
HistoRx Incorporated, based in New Haven, Connecticut, is a bioscience company known for its tissue-based, quantitative molecular pathology analysis system. The AQUA (TM) Platform for Quantitative Pathology provides researchers and clinicians with high-throughput tissue analysis features. The system's tissue imaging microscopy equipment and analysis software automate assessment processes. The AQUA Platform for Quantitative Pathology handles large data volumes. It generates accurate information on the molecular biology of diseased tissue. The system streamlines drug discovery, disease diagnosis, clinical pathology, and patient care data processing. It can be used to discover new protein biomarkers, identify drug targets, match therapies to tumors' molecular profiles, assess tumor responses to therapies, monitor the progression of diseases. The AQUA Platform for Quantitative Pathology provides users with fluorescence-based colocalization, subcellular localization, and other features. HistoRx systems employ technology developed in 2000 by researchers at the Yale School of Medicine.
|